A Mounjaro denial letter can be hard to decode. Here is how to read it, check the indication and ICD-10 codes, and build a solid appeal file under ANS rules.
Why the coverage letter deserves a close read
Your health plan's reply lands in your inbox, and after two paragraphs you still can't tell whether Mounjaro was approved. You're not alone. Mounjaro insurance coverage letters tend to be short, dense, and full of reference numbers, and the answer you need often hides in a single line. Before you call anyone or start an appeal, slow down and read the letter the way an auditor would.
Most denials come from standard templates. The useful details sit in the reference numbers and the stated basis, not in the friendly opening sentence. Our MounjaBlog guides break this down line by line, which makes a good starting point before you pick up the phone.
What a denial letter usually contains
Grab a highlighter and look for three things first. Most standard denials include:
- The protocol number, which identifies this specific request and should appear in every contact.
- The stated basis, such as “not in the ANS list,” “indication not covered,” “missing prior authorization,” or “off-label use.”
- The appeal deadline and channel, whether that's an online portal, an email address, or a written request.
The stated basis matters most. Insurers word their denials differently, so compare your letter with the exact phrase it uses, not with a forum post about someone else's case. Underline that sentence, because your appeal should answer it directly. Then confirm the deadline in your contract rather than trusting a date you read online.
Also check the scope. Does the denial cover the whole request, or only part of it? A plan might approve the pen but refuse pharmacy dispensing, or approve one dose strength while rejecting another. A partial denial needs its own response, so list each affected item in writing. Confirm that the drug name, the dose, and the prescribing doctor on the letter match your prescription, too.
The indication decides a lot
In Brazil, Anvisa approves each medicine's uses, and those uses appear in the bula, the official package insert. Open the current bula in Anvisa's Bulário Eletrônico, find the indication section, and copy the exact line into your file. Work from that text, not from memory or a summary. The reviewer will read the official wording, so your file should match it.
Why does this matter so much? Some plans review a request for weight management differently from one for type 2 diabetes. A prescription tied to diabetes may follow a different path than one tied to obesity, even though the medicine is the same. That difference explains why two letters that look alike can lead to different answers.
Diagnosis codes add another layer. Two ICD-10 codes relevant here are E11 for type 2 diabetes and E66 for obesity. Check both against the WHO ICD-10 browser before you rely on them. Then make sure the code on the prescription matches the code in the doctor's report. A mismatch among these three can give the plan a reason to refuse, and a corrected letter can often fix it.
The ANS list and the 2022 change in the law
The ANS Rol de Procedimentos e Eventos em Saúde is the reference list of procedures and health events that plans must cover under the rules the agency sets. The ANS updates it periodically. The version that counts is the one in force on the date of your request, so check it directly rather than relying on an old copy.
For years, people have debated whether the list is exhaustive, meaning that anything missing from it can be refused. Lei 14.454/2022 changed part of that picture. It allows coverage beyond the list when specific criteria are met.
According to the amended text of article 10 of Lei 9.656/1998, those criteria involve scientific evidence of efficacy and a recommendation from a health technology assessment body, such as Conitec or a recognized international body. The exact wording and deadlines decide your case, so read the law yourself. Then check ANS publications on how they apply.
Contract date matters too. Contracts signed after the 1998 law took effect in 1999 generally follow its full rules, while older contracts may be treated differently. If yours is older, ask the ANS or your insurer which framework applies before you assume the standard rules fit.
For questions about these rules, start with the ANS consumer channels. Check the current contact details on the ANS website, since older numbers in forums or old letters may no longer work. Our MounjaBlog resource page on coverage rules collects the links and steps we use when we explain these documents to readers.
Building the appeal file
An appeal is only as strong as its paperwork. Start with a letter from your doctor that states the diagnosis and its ICD-10 code, the dose requested, and your treatment history. Add recent lab results, such as HbA1c, with their collection dates.
Include a copy of the prescription and the bula excerpt showing the indication you copied earlier. Keep originals safe, send copies, and store everything in one folder.
Keep a dated log of every contact with the plan. Record the date, the channel, the protocol number, the attendant's name, and what was said or promised. A note on your phone works well, as long as you update it right after each call. If someone promises a reply by a certain day, write it down.
Your doctor should answer the specific denial reason in writing. Resending the original prescription rarely addresses why the plan refused it. Ask the doctor to explain, point by point, how your case fits the indication and the code, and why this treatment suits you.
Some plans also ask about previous treatments. Ask your doctor which earlier treatments are relevant to include. Don't change or stop any medication on your own to satisfy a plan's form. Those decisions belong with your doctor.
When coverage is partial or denied: the cost side
Before you decide what to do, estimate what you might pay out of pocket. Your contract explains copayment rules, often called coparticipação, and those rules vary from plan to plan. Read that section and any cost cap, then calculate a realistic monthly total. Include the pen, any pharmacy fee, and consultation costs. Seeing the number on paper makes the choice easier.
Money pressure can push people toward sellers with low prices, no prescription, or unclear sourcing. Those products carry real risk because nobody can confirm what's inside. Before you buy anything, check the product's registration in Anvisa's Bulário Eletrônico, and approach any seller who can't show it with serious caution.
Ask your prescribing doctor whether any alternative on the plan's formulary is clinically appropriate for you. That call belongs to your doctor, not to the plan and not to this article. If a switch is suggested, ask for the reasoning in writing and make sure you understand what it means for your costs and follow-up.
Questions to ask the insurer, and where to go next
Open every call or message with three requests: the denial reason in writing, the exact appeal route, and the deadline. Then ask whether a second review by a different medical auditor is possible, and how long that review takes. Get each answer in writing and add it to your log.
If the appeal fails, you still have options. The ANS receives complaints about health plans and can check whether an operator followed its rules. The Código de Defesa do Consumidor also protects consumers in many disputes, so a lawyer can tell you which route fits your case. For complex cases, especially when the contract date, the 2022 law change, or a partial denial raises legal questions, a lawyer is worth consulting.
Keep the whole process in one folder with your letters, your log, and your evidence. If you want help shaping your questions before you call or write, the MounjaBlog community questions page is a practical place to organize them, so each conversation starts with a clear list in hand.
FAQ
Does health plan insurance cover Mounjaro for type 2 diabetes?
It depends on your contract, the ANS rules in force on the request date, and whether the prescription matches the indication in the bula and the diagnosis code. Ask the insurer for the specific basis of any denial so you can respond to it directly.
What is the ANS Rol de Procedimentos e Eventos em Saúde?
It is the reference list of procedures and health events that plans must cover under ANS rules. The ANS updates it periodically, and Lei 14.454/2022 allows coverage beyond the list in certain cases that meet specific criteria.
Can I appeal a partial denial?
Yes. Identify which items were refused, such as the pen, the dispensing, or a specific dose, and address each one. Follow the deadline and channel shown in the letter and in your contract.
Should I buy Mounjaro from another seller while my appeal is pending?
Be cautious. Unverified sellers can't confirm what's in their products, so check registration in Anvisa's Bulário Eletrônico and talk with your prescribing doctor before you buy anything.
Sources
- Lei 9.656/1998 (Planos de Assistência à Saúde)
- Lei 14.454/2022 (alteração da Lei 9.656/1998)
- Lei 8.078/1990 (Código de Defesa do Consumidor)
- ANS - Rol de Procedimentos e Eventos em Saúde
- ANS - Canais de atendimento
- Anvisa - Bulário Eletrônico (consulta a bulas)
- WHO International Classification of Diseases ICD-10 Browser
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app